Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04627727 · ClinicalTrials.gov registry record · Early Phase 1
Effect of a Low FODMAP Diet on SIBO Breath Test Positivity
A Early Phase 1 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
NCT04627727 is a Early Phase 1 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT04627727, a Early Phase 1 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
Bloating is the most common symptom associated with disorders of brain-gut interaction (i.e., functional bowel disorders) such as irritable bowel syndrome, a disorder characterized by abdominal pain and altered bowel habits which affects up to 11% of world population. A common cause of bloating is small intestinal bacterial overgrowth (SIBO), a condition defined by excessive and/or abnormal type of bacteria in the small bowel. The potential role of SIBO for irritable bowel syndrome (IBS) was initially proposed by Pimentel et al. Using lactulose breath tests (LBTs), 78% of patients with IBS were also diagnosed with SIBO. After antibiotic therapy, 48% of patients no longer met the Rome criteria for IBS. A recent systematic review and meta-analysis concluded that the prevalence of SIBO is increased in IBS.
Interventions
- OTHER low FODMAP diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-11-15 |
| Est. Completion | 2024-12-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04627727
The ClinicalTrials.gov registry entry for NCT04627727 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which low FODMAP diet is the first listed.
NCT04627727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04627727 about?
NCT04627727 is a clinical study titled "Effect of a Low FODMAP Diet on SIBO Breath Test Positivity". Bloating is the most common symptom associated with disorders of brain-gut interaction (i.e., functional bowel disorders) such as irritable bowel syndrome, a disorder characterized by abdominal pain and altered bowel habits which affects up to 11% of world population. A common cause of bloating is s...
What is the current status of trial NCT04627727?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2020-11-15. Estimated completion is 2024-12-15.
What interventions are being tested in trial NCT04627727?
The interventions under investigation include: low FODMAP diet (OTHER).
Who is sponsoring clinical trial NCT04627727?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.